In our previous study, we analyzed the expression level of BEX2 in 290 CRC patients in the GSE14333 sample cohort and observed that BEX2 expression levels were significantly higher in Dukes D stage patients than in other stage patients 11. This evidence concerns the gene BEX2 and colorectal carcinoma.